Basic Information
DUKORAL VACCINE AGAINST CHOLERA AND ETEC-DIARRHOEA
SUSPENSION
Regulatory Information
SIN12186P
February 6, 2003
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 4, 2025
XJ07AE01
Company Information
AENON PHARMACEUTICALS SEA PTE. LTD.
AENON PHARMACEUTICALS SEA PTE. LTD.
Active Ingredients
Strength: 1 mg/dose
Strength: 31.25 x 10^9 bacteria
Strength: 31.25 x 10^9 bacteria
Strength: 31.25 x 10^9 bacteria
Strength: 31.25 x 10^9 bacteria
Detailed Information
Contraindications
**CONTRAINDICATIONS** Hypersensitivity to the active substances, to any of the excipients or to formaldehyde. Administration of **DUKORAL** ® should be postponed for subjects suffering from acute gastrointestinal illness or acute febrile illness.
Indication Information
**INDICATIONS** _Cholera:_ Active immunisation of adults and children from 2 years of age who will be visiting areas with an ongoing or anticipated epidemic or who will be spending an extended period of time in areas in which cholera infection is a risk. _ETEC_: Active immunisation of adults and children from 2 years of age who will be visiting areas posing a great risk of diarrheal illness caused by enterotoxigenic _Escherichia coli_ (ETEC), one of the most common causes of “travellers’ diarrhea”. **DUKORAL** ® should not replace standard protective measures. In the event of diarrhea measures of rehydration should be instituted.